US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPS Medical Breakthroughs ETF

62.20

-1.5276-2.40%

Post-market: 62.12-0.0806-0.13%19:30 EDT

Volume:19.49K

Turnover:1.21M

Market Cap:225.48M

PE:- -

High:63.39

Open:63.10

Low:61.96

Close:63.73

52wk High:70.85

52wk Low:36.32

Shares:3.63M

Float Shares:3.63M

Volume Ratio:0.41

T/O Rate:0.54%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CG Oncology Q2 Net Loss Widens on Higher R&D Costs

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS

CG Oncology Q2 EPS USD -0.9

THOMSON REUTERS

CG Oncology Inc - Files for Offering of up to $500 Mln Common Stock - SEC Filing

THOMSON REUTERS

Market Chatter: AbbVie Launches $10 Billion Bond Sale to Fund Apogee Acquisition

MT Newswires Live

Abbvie Seeks at Least $8 Billion in Debt to Fund Apogee Deal - Bloomberg News

THOMSON REUTERS

Abbvie : Plans to Use Note Offering Proceeds for Apogee Therapeutics Acquisition Funding

THOMSON REUTERS

Street View: Strength in AbbVie's Immunology Pipeline to Support Revenue Growth

Xenon Pharma Grants 32,758 Inducement Stock Options, 19,013 RSUs to New Hires

Xenon Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sector Update: Healthcare

MT Newswires Live

AbbVie Lowers Outlook to Account for Acquisition, as 2Q Profit Jumps

Abbvie Shares Down 3.6% Premarket After Co Cuts 2026 Profit Forecast on Apogee Buy

THOMSON REUTERS

AbbVie Trims 2026 Profit Forecast on Apogee Buy, Beats Second-quarter Estimates

Health Rounds: Experimental Cell Therapy Slows Heart Failure Progression in Duchenne Muscular Dystrophy

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)

CG Oncology announces publication of BOND-003 results in The Lancet Oncology

CG Oncology Says Phase 3 Bond-003 Data for Cretostimogene in BCG-unresponsive Bladder Cancer Publish in Lancet Oncology

Oppenheimer would own Capricor Therapeutics into committee meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/SBIO/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","market":"US","secType":"STK","nameCN":"ALPS Medical Breakthroughs ETF","latestPrice":62.2006,"timestamp":1789761600000,"preClose":63.7282,"halted":0,"volume":19490,"hourTrading":{"tag":"盘后","latestPrice":62.12,"preClose":62.2006,"latestTime":"19:30 EDT","volume":18,"amount":1107.3954,"timestamp":1789774205561,"change":-0.0806,"changeRate":-0.001296,"amplitude":0},"delay":0,"changeRate":-0.023970549929230697,"floatShares":3625000,"shares":3625000,"eps":0,"marketStatus":"Not Yet Opened","change":-1.5276,"latestTime":"09-18 16:00:00 EDT","open":63.1,"high":63.385,"low":61.96,"amount":1214539.54164,"amplitude":0.022361,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":63.7282,"sharesOutstanding":2675000,"nav":62.25,"aum":225655960.35,"bidAskSpread":0.002808,"postHourTrading":{"tag":"盘后","latestPrice":62.12,"preClose":62.2006,"latestTime":"19:30 EDT","volume":18,"amount":1107.3954,"timestamp":1789774205561,"change":-0.0806,"changeRate":-0.001296,"amplitude":0},"volumeRatio":0.4133107687792956,"impliedVol":0.2645,"impliedVolPercentile":0.8446},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","floatShares":3625000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4133107687792956,"shares":3625000,"dividePrice":0,"high":63.385,"amplitude":0.022361,"preClose":63.7282,"low":61.96,"week52Low":36.32,"pbRate":"--","week52High":70.85,"institutionHeld":0,"latestPrice":62.2006,"eps":0,"divideRate":0,"volume":19490,"delay":0,"ttmEps":0,"open":63.1,"prevYearClose":51.22,"prevWeekClose":63.29,"prevMonthClose":66.82,"prevQuarterClose":64.65,"fiveDayClose":63.29,"twentyDayClose":68.56,"sixtyDayClose":60.843},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBIO\",params:#limit:5,,,undefined,":[{"date":"2024-12-19","symbol":"SBIO","amount":1.17346,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-19","defaultRemindTime":1734618600000,"name":"ALPS Medical Breakthroughs ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-19","currency":"USD","dateTimestamp":1734584400000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"SBIO","amount":0.07106,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"},{"market":"US","date":"2019-12-19","symbol":"SBIO","amount":0.01585,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2019-12-27","payableDate":"2019-12-20","currency":"USD","type":"dividend","dateTimestamp":1576731600000},{"market":"US","date":"2018-12-20","symbol":"SBIO","amount":0.78406,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2018-12-27","payableDate":"2018-12-21","currency":"USD","type":"dividend","dateTimestamp":1545282000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBIO\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.78406,"currency":"USD"},{"executeDate":"2019-12-19","recordDate":"2019-12-20","paymentDate":"2019-12-27","value":0.01585,"currency":"USD"},{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.07106,"currency":"USD"},{"executeDate":"2024-12-19","recordDate":"2024-12-19","paymentDate":"2024-12-26","value":1.17346,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBIO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBIO\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657063925","title":"CG Oncology Q2 Net Loss Widens on Higher R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657063925","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657063925?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:22","pubTimestamp":1786018956,"startTime":"0","endTime":"0","summary":"CG Oncology Q2 net loss widens on higher R&D costsOverviewUS biopharmaceutical firm's Q2 rev rose to $1.2 mln, reflecting early commercialization activityNet loss widened to $79.1 mln, driven by highe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4430OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","SBIO","AVTX","BK4535","CMPX","CHRS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657639609","title":"CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657639609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657639609?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:15","pubTimestamp":1786018501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA70KC8F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SBIO","BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657396066","title":"CG Oncology Q2 EPS USD -0.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2657396066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657396066?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:15","pubTimestamp":1786018500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXHMKD13:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SBIO","BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657263613","title":"CG Oncology Inc - Files for Offering of up to $500 Mln Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657263613","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657263613?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:02","pubTimestamp":1786017778,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4430WM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SBIO","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657633115","title":"Market Chatter: AbbVie Launches $10 Billion Bond Sale to Fund Apogee Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2657633115","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657633115?lang=en_us&edition=fundamental","pubTime":"2026-08-05 01:40","pubTimestamp":1785865235,"startTime":"0","endTime":"0","summary":"AbbVie  has commenced a $10 billion investment-grade bond sale to help finance its pending acquisition of Apogee Therapeutics , Bloomberg reported Tuesday, citing people with direct knowledge of the matter.The offering, which includes bonds maturing in two to 40 years, has drawn about $63 billion of peak demand, the report said, citing the people.AbbVie didn't immediately reply to a request for comment from MT Newswires.Price: 243.24, Change: -1.86, Percent Change: -0.76","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JDOC","IYH","MEDX","VHT","XLV","PJP","LU0395794307.EUR","GLAM","TLTW","LU1934455863.HKD","US7Y.BOND","FHLC","RXL","LU0912757837.SGD","SBIO","IE00BVYPNV92.GBP","LU0943347566.SGD","TMF","LU1162221912.USD","LU0203345920.USD","PPH","LU0511384066.AUD","LU0211328371.USD","LU0738911758.USD","LU1923622614.USD","US12M.BOND","TLT","LU1037948541.HKD","LU2347655073.USD","FTXH","LU2087621335.USD","LU1244550221.USD","APGE","TRUH","LU1093756168.USD","US6M.BOND","LU1267930490.SGD","LU0310799852.SGD","LU1585245621.USD","IXJ","LU1551013342.USD","US3Y.BOND","LU0859254822.USD","US5Y.BOND","AGNG","US30Y.BOND","US2Y.BOND","IE00BJJMRZ35.SGD","US10Y.BOND","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656590975","title":"Abbvie Seeks at Least $8 Billion in Debt to Fund Apogee Deal - Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2656590975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656590975?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:17","pubTimestamp":1785849448,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4410VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089284900.SGD","LU0965508806.USD","LU1670628061.USD","FTXH","IE00BFTCPJ56.SGD","LU0198837287.USD","JDOC","LU2125909593.SGD","LU0289961442.SGD","LU0122379950.USD","LU1244550494.USD","LU0211328371.USD","LU1093756325.SGD","VHT","SBIO","LU2357627491.SGD","LU0203347892.USD","MEDX","IYH","LU2237443622.USD","IE00B42XCP33.USD","LU1551013342.USD","ABBV","LU1989771016.USD","LU2468319806.SGD","SG9999015952.SGD","APGE","LU0029864427.USD","LU0726765562.USD","LU0661504455.SGD","GLAM","IE000MB6IJN5.SGD","LU0289739343.SGD","AGNG","LU0058720904.USD","FHLC","LU0820561909.HKD","RXL","LU0861579265.USD","IE00BDGV0183.EUR","TRUH","IXJ","SG9999003800.SGD","LU0053671581.USD","IE00BVYPNW00.USD","LU2433249047.HKD","XLV","PJP","LU1551013425.SGD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656550225","title":"Abbvie : Plans to Use Note Offering Proceeds for Apogee Therapeutics Acquisition Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2656550225","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656550225?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:20","pubTimestamp":1785846049,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4411E4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1037948541.HKD","TRUH","LU1934455194.USD","ABBV","IE00B42XCP33.USD","PJP","LU0395794307.EUR","AGNG","GLAM","LU0320765646.SGD","JDOC","LU0795875169.SGD","LU1732799900.SGD","LU1718418525.SGD","APGE","IXJ","LU0198837287.USD","LU0726765562.USD","FHLC","LU0289739343.SGD","LU1291159041.SGD","SG9999011175.SGD","LU1585245621.USD","IE00BFTCPJ56.SGD","LU1244550577.SGD","LU1057294990.SGD","SBIO","FTXH","LU2125909593.SGD","VHT","IE00BGHQF631.EUR","LU1074936037.SGD","LU2112291526.USD","LU2237443895.HKD","XLV","LU0211327993.USD","PPH","RXL","IE0002141913.USD","IE000F7OJYX1.SGD","MEDX","LU2089284900.SGD","LU0708994859.HKD","LU2089984988.USD","IE00BVYPNV92.GBP","IYH","LU2023251221.USD","LU1934455277.USD","LU0868494617.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656837519","title":"Street View: Strength in AbbVie's Immunology Pipeline to Support Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2656837519","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656837519?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:32","pubTimestamp":1785756728,"startTime":"0","endTime":"0","summary":"BUZZ-Street View: Strength in AbbVie's immunology pipeline to support revenue growth** AbbVieABBV.Nslightly trimmed its 2026profit forecaston Friday to account for its planned Apogee Therapeutics acqu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4N4400Y0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","LU0170899867.USD","LU2433249047.HKD","RXL","LU0912757837.SGD","IE000BZT7R73.USD","IE00BLSP4239.USD","LU1003077747.HKD","FTXH","LU0965509283.SGD","PJP","FHLC","LU1496350171.SGD","LU1934455194.USD","LU1551013425.SGD","LU0545039389.USD","LU0256863811.USD","TRUH","SBIO","IE000WAW04H5.SGD","LU0289739699.SGD","LU0738911758.USD","LU1732800096.USD","LU0689626769.HKD","LU0053671581.USD","IE00BVYPNV92.GBP","IE00B2B36J28.USD","AGNG","JDOC","LU0689472784.USD","LU0861579265.USD","IE00BBT3K403.USD","LU1934455863.HKD","IE0002270589.USD","IXJ","LU2468319806.SGD","XLV","IE00B42XCP33.USD","BK4550","PPH","LU1061106388.HKD","LU2087621335.USD","MEDX","ABBV","LU0820561909.HKD","APGE","LU2237443622.USD","VHT","IE00BVYPNW00.USD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656585399","title":"Xenon Pharma Grants 32,758 Inducement Stock Options, 19,013 RSUs to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2656585399","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656585399?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:01","pubTimestamp":1785528080,"startTime":"0","endTime":"0","summary":"Xenon Pharma grants 32,758 inducement stock options, 19,013 RSUs to new hiresXenon Pharmaceuticals granted inducement equity awards to 11 new non-officer employees, totaling 32,758 share options and 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDLbfcL3N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014013.SGD","LU2210150020.SGD","BK4112","IE00BGHQF748.EUR","SG9999014021.USD","BK4139","IE00BN0W2T93.GBP","IE00BKPKM429.USD","SG9999014039.USD","NDAQ","LU2210149790.SGD","BCDF","BK4588","XENE","SBIO","LU2095319765.USD","IBRN","IE00BN0W2V16.EUR","LU0314104364.USD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","BK4585","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656399370","title":"Xenon Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656399370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656399370?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:01","pubTimestamp":1785528060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nTUA7BSC6X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SBIO","IBRN","XENE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656391209","title":"Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391209","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391209?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:01","pubTimestamp":1785528060,"startTime":"0","endTime":"0","summary":"VANCOUVER, BC and BOSTON, MA, July  31, 2026  (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical deve","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/31/3337042/33485/en/Xenon-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SBIO","IBRN","LCLG","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656393679","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2656393679","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656393679?lang=en_us&edition=fundamental","pubTime":"2026-08-01 00:57","pubTimestamp":1785517053,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index shedding 0.8% and the State Street Health Care Select Sector SPDR ETF  decreasing 0.5%.The iShares Biotechnology ETF  fell 2.2%.In corporate news, AbbVie  lowered its full-year earnings guidance on Friday to account for the expected dilution from its planned acquisition of Apogee Therapeutics , despite reporting stronger-than-expected Q2 results. AbbVie shares were down 2%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","PPH","AGNG","BK4534","LU2129689605.HKD","LU1093756325.SGD","RXL","SBIO","XBI","IE0009355771.USD","IE00BLSP4452.SGD","JDOC","IYH","FHLC","IXJ","LU1244550494.USD","LU0310800379.SGD","IE0004445239.USD","LU2237443622.USD","LU0395794307.EUR","GLAM","APGE","LU0868494708.USD","VHT","FTXH","LU2237443978.SGD","MEDX","XLV","HCSG","LU0949170772.SGD","SG9999015986.USD","IE0002141913.USD","LU0058720904.USD","LU0029864427.USD","BK4581","IE00B2B36J28.USD","LU0124676726.USD","LU0128525929.USD","LU1023059063.AUD","SG9999001440.SGD","LU0965509010.AUD","LU0289739699.SGD","LU1732800096.USD","LU0198837287.USD","LU0320765646.SGD","PJP","TRUH","LABU","IE00BFTCPJ56.SGD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655293366","title":"AbbVie Lowers Outlook to Account for Acquisition, as 2Q Profit Jumps","url":"https://stock-news.laohu8.com/highlight/detail?id=2655293366","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655293366?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:27","pubTimestamp":1785500820,"startTime":"0","endTime":"0","summary":"AbbVie lowered its full-year adjusted earnings outlook to account for its acquisition of Apogee Therapeutics, as the company logged higher profit and revenue in the recent quarter.The pharmaceutical c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JOYT","LU0708994859.HKD","IXJ","LU2237443465.HKD","RXL","TRUH","PPH","GLAM","FEBU","SG9999015978.USD","SG9999011175.SGD","LU1585245621.USD","IE00BVYPNV92.GBP","VGFPF","LU0256863811.USD","APGE","LU1989772840.SGD","IE00B19Z3581.USD","IE0002141913.USD","JDOC","LU0456855351.SGD","LU0417517546.SGD","FTXH","MEDX","LU1732799900.SGD","LU0057025933.USD","GXDW","IE00BGHQF631.EUR","AGNG","RGLO","SBIO","BK4550","IYH","LU1670628061.USD","LU1023059063.AUD","LU0511384066.AUD","DECU","ABBV","PMDE","LU1291159041.SGD","FHLC","LU1934455863.HKD","PJP","VHT","VOTE","LU0965509283.SGD","XLV","LU0170899867.USD","LU1037948897.HKD","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655656163","title":"Abbvie Shares Down 3.6% Premarket After Co Cuts 2026 Profit Forecast on Apogee Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2655656163","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655656163?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:50","pubTimestamp":1785498658,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4N43X1CJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1551013425.SGD","LU0689472784.USD","XLV","PJP","SG9999001440.SGD","IE00BFTCPJ56.SGD","IE00BVYPNW00.USD","IE00B19Z3B42.SGD","JDOC","SG9999015945.SGD","LU2347655156.SGD","LU0456855351.SGD","IE0002141913.USD","MEDX","LU1718418525.SGD","LU2089984988.USD","SBIO","LU0689626769.HKD","TRUH","LU1670628061.USD","LU0820561909.HKD","LU0170899867.USD","LU1061106388.HKD","IE00BSNM7G36.USD","PPH","VHT","AGNG","IXJ","IE000BZT7R73.USD","LU0203347892.USD","ABBV","LU1732800096.USD","FTXH","GLAM","APGE","LU1037948541.HKD","LU2129689431.USD","RXL","LU2087621335.USD","IE000MB6IJN5.SGD","IYH","LU0738911758.USD","BK4559","FHLC","LU0211328371.USD","LU1839511570.USD","SG9999015952.SGD","BK4588","LU0965509283.SGD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655655533","title":"AbbVie Trims 2026 Profit Forecast on Apogee Buy, Beats Second-quarter Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2655655533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655655533?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:48","pubTimestamp":1785498512,"startTime":"0","endTime":"0","summary":"AbbVie trims 2026 profit forecast on Apogee buy, beats second-quarter estimatesJuly 31 (Reuters)-AbbVieABBV.Non Friday trimmed its 2026 profit forecast to account for its planned Apogee Therapeutics a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4N43X0YB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JDOC","LU1989771016.USD","LU0203347892.USD","LU1496350502.SGD","XLV","LU0256863811.USD","LU2089283258.USD","PPH","LU2237443978.SGD","RXL","IE000SO60NU8.SGD","BK4534","FHLC","LU0456855351.SGD","LU0965509101.SGD","MEDX","SBIO","GLAM","APGE","LU1267930573.SGD","LU0170899867.USD","LU1989772923.USD","LU0868494708.USD","LU1162221912.USD","BK4550","VHT","LU0114720955.EUR","AGNG","ABBV","IYH","LU0158827948.USD","LU0289961442.SGD","LU1934455277.USD","LU2237443465.HKD","IE00BVYPNW00.USD","IE00BBT3K403.USD","LU1003077747.HKD","LU1037948541.HKD","IE00BLSP4239.USD","LU2089284900.SGD","PJP","IXJ","IE00BJT1NW94.SGD","LU0859254822.USD","LU1983299246.USD","LU0912757837.SGD","LU2112291526.USD","LU0320765646.SGD","FTXH","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800214","title":"Health Rounds: Experimental Cell Therapy Slows Heart Failure Progression in Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655800214?lang=en_us&edition=fundamental","pubTime":"2026-07-31 02:55","pubTimestamp":1785437705,"startTime":"0","endTime":"0","summary":"Health Rounds: Experimental cell therapy slows heart failure progression in Duchenne muscular dystrophyJuly 30 -Hello Health Rounds readers!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43W1BF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON","CAPR","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654885962","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654885962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654885962?lang=en_us&edition=fundamental","pubTime":"2026-07-28 23:20","pubTimestamp":1785252006,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Phibro Animal Health (PAHC), Universal Health (UHS...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-phibro-animal-health-pahc-universal-health-uhs-and-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-phibro-animal-health-pahc-universal-health-uhs-and-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","CGON","BK4585","PAHC","IE00B64PRP62.GBP","BK4581","XLV","GPZ","LABU","LU0029874061.USD","BK4137","BK4139","IE00B3QW5Z07.USD","CG","XBI","SBIO","BK4185","BK4007","IE00BGHQF748.EUR","BK4588","HCSG","BK4135","UHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654002626","title":"CG Oncology announces publication of BOND-003 results in The Lancet Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2654002626","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654002626?lang=en_us&edition=fundamental","pubTime":"2026-07-28 06:50","pubTimestamp":1785192608,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) announced the publication of results from the pivotal Phase 3 BOND-003 Cohort C trial evaluating cretostimogene grenadenorepvec ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-announces-publication-of-bond-003-results-in-the-lancet-oncology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-announces-publication-of-bond-003-results-in-the-lancet-oncology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BOND","IE00B64PRP62.GBP","BK4588","GPZ","BK4585","IE00B3QW5Z07.USD","CGON","SBIO","CG","IE00BGHQF748.EUR","BK4135","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654302613","title":"CG Oncology Says Phase 3 Bond-003 Data for Cretostimogene in BCG-unresponsive Bladder Cancer Publish in Lancet Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2654302613","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654302613?lang=en_us&edition=fundamental","pubTime":"2026-07-28 06:46","pubTimestamp":1785192363,"startTime":"0","endTime":"0","summary":"CG Oncology says Phase 3 BOND-003 data for cretostimogene in BCG-unresponsive bladder cancer publish in Lancet OncologyCG Oncology reported publication of pivotal Phase 3 BOND-003 Cohort C results in ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL6LLX4c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","BK4112","SG9999014005.SGD","SG9999014013.SGD","LU2210149790.SGD","LU0314104364.USD","BCDF","SBIO","SG9999014039.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4588","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","NDAQ","CGON","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654045069","title":"Oppenheimer would own Capricor Therapeutics into committee meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2654045069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654045069?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:20","pubTimestamp":1785162008,"startTime":"0","endTime":"0","summary":"After briefing documents for this Wednesday’s FDA advisory committee for deramiocel became available this morning, Oppenheimer analyst Leland Gersh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oppenheimer-would-own-capricor-therapeutics-into-committee-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oppenheimer-would-own-capricor-therapeutics-into-committee-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","FBT","OPY","SBIO","IBRN","BK4139","BK4585","BBH","BBP","XBIX","BK4127","CAPR","LABU","PBE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":112,"code":"91000000","status":"200"}]}}